Dried blood spot testing: Filling the gap between antiretroviral treatment & monitoring in India

Indian Journal of Medical Research

Volumn 136, Issue 6, 2012, Pages 903-905

  Zazzi, M ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; CD4 LYMPHOCYTE COUNT; COST; DRIED BLOOD SPOT TESTING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; RNA DEGRADATION; RNA EXTRACTION; VIREMIA; VIRUS LOAD; GENETICS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; PROCEDURES;

DRIED BLOOD SPOT TESTING; HIV INFECTIONS; HIV-1; HUMANS; RNA, VIRAL; VIRAL LOAD;

EID: 84873163874     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. United Nations General Assembly. Political Declaration on HIV/AIDS: Intensifying our Efforts to Eliminate HIV/ AIDS. July 8, 2011 New York. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/document/2011/06/20/110610unares-65-277en.pdf, accessed on November 24, 2012.
2. Walker AS, Gibb DM. Monitoring of highly active antiretroviral therapy in HIV infection. Curr Opin Infect Dis 2011; 24: 27-33.
3. De Luca A, Prosperi M, Bracciale L. Resistance considerations in sequencing of antiretroviral therapy in low-middle income countries with currently available options. Curr Opin HIV AIDS 2010; 5: 27-37.
4. Cassol S, Gill MJ, Pilon R, Cormier M, Voigt RF, Willoughby B, et al. Quantifcation of human immunodefciency virus type 1 RNA from dried plasma spots collected on flter paper. J Clin Microbiol 1997; 35: 2795-801.
5. Fiscus SA, Brambilla D, Grosso L, Schock J, Cronin M. Quantitation of human immunodefciency virus type 1 RNA in plasma by using blood dried on flter paper. J Clin Microbiol 1998; 36: 258-60.
6. Mwaba P, Cassol S, Nunn A, Pilon R, Chintu C, Janes M, Zumla A. Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients. Lancet 2003; 362: 2067-8.
7. Marconi A, Balestrieri M, Comastri G, Pulvirenti FR, Gennari W, Tagliazucchi S, et al. Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens. Clin Microbiol Infect 2009; 15: 93-7.
8. Pirillo MF, Recordon-Pinson P, Andreotti M, Mancini MG, Amici R, Giuliano M. Quantifcation of HIV-RNA from dried blood spots using the Siemens VERSANT® HIV-1 RNA (kPCR) assay. J Antimicrob Chemother 2011; 66: 2823-6.
9. van Deursen P, Oosterlaken T, Andre P, Verhoeven A, Bertens L, Trabaud MA, et al. Measuring human immunodefciency virus type 1 RNA loads in dried blood spot specimens using NucliSENS EasyQ HIV-1 v2.0. J Clin Virol 2010; 47: 120-5.
10. Okonji JA, Basavaraju SV, Mwangi J, Shiraishi RW, Odera M, Ouma K, et al. Comparison of HIV-1 detection in plasma specimens and dried blood spots using the Roche COBAS Ampliscreen HIV-1 test in Kisumu, Kenya. J Virol Methods 2012; 179: 21-5.
11. Neogi U, Gupta S, Rodrigues R, Sahoo PN, Rao SD, Rewari BB, et al. Dried blood spot HIV-1 RNA quantifcation: A useful tool for viral load monitoring among HIV-infected individuals in India. Indian J Med Res 2012; 136: 956-62.
12. Vidya M, Saravanan S, Rifkin S, Solomon SS, Waldrop G, Mayer KH, et al. Dried blood spots versus plasma for the quantitation of HIV-1 RNA using a real-Time PCR, m2000rt assay. J Virol Methods 2012; 181: 177-81.
13. Garrido C, Zahonero N, Corral A, Arredondo M, Soriano V, de Mendoza C. Correlation between human immunodefciency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests. J Clin Microbiol 2009; 47: 1031-6.
14. Mbida AD, Sosso S, Flori P, Saoudin H, Lawrence P, Monny-Lobé M, et al. Measure of viral load by using the Abbott RealTime HIV-1 assay on dried blood and plasma spot specimens collected in 2 rural dispensaries in Cameroon. J Acquir Immune Defc Syndr 2009; 52: 9-16.
15. Arredondo M, Garrido C, Parkin N, Zahonero N, Bertagnolio S, Soriano V, et al. Comparison of HIV-1 RNA measurements obtained by using plasma and dried blood spots in the automated Abbott real-time viral load assay. J Clin Microbiol 2012; 50: 569-72.
16. Hamers RL, Smit PW, Stevens W, Schuurman R, Rinke de Wit TF. Dried fuid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir Ther 2009; 14: 619-29.
17. Hearps AC, Ryan CE, Morris LM, Plate MM, Greengrass V, Crowe SM. Stability of dried blood spots for HIV-1 drug resistance analysis. Curr HIV Res 2010; 8: 134-40.
18. Monleau M, Butel C, Delaporte E, Boillot F, Peeters M. Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantifcation and PCR amplifcation for drug resistance genotyping. J Antimicrob Chemother 2010; 65: 1562-6.
19. Hatano H, Hunt P, Weidler J, Coakley E, Hoh R, Liegler T, et al. Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen. Clin Infect Dis 2006; 43: 1329-36.